↓ Skip to main content

Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran

Overview of attention for article published in Molecular Diagnosis & Therapy, December 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
Published in
Molecular Diagnosis & Therapy, December 2019
DOI 10.1007/s40291-019-00438-6
Pubmed ID
Authors

Pedro Renato de Paula Brandão, Simoneide S. Titze-de-Almeida, Ricardo Titze-de-Almeida

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 33%
Other 3 13%
Researcher 3 13%
Lecturer > Senior Lecturer 1 4%
Student > Master 1 4%
Other 1 4%
Unknown 7 29%
Readers by discipline Count As %
Chemistry 6 25%
Medicine and Dentistry 3 13%
Biochemistry, Genetics and Molecular Biology 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Environmental Science 1 4%
Other 2 8%
Unknown 7 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2019.
All research outputs
#12,060,794
of 15,161,635 outputs
Outputs from Molecular Diagnosis & Therapy
#166
of 258 outputs
Outputs of similar age
#249,266
of 345,776 outputs
Outputs of similar age from Molecular Diagnosis & Therapy
#2
of 5 outputs
Altmetric has tracked 15,161,635 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 258 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,776 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.